Probenecid effect on cefuroxime pharmacokinetics in calves

Cefuroxime pharmacokinetics were studied in unweaned calves. The antibiotic was administered at 10 mg/kg to six calves i.v., to 12 calves i.m. and to ten of the previous 12 calves i.m. at 10 mg/kg together with probenecid at 40 mg/kg. Intramuscular doses of cefuroxime alone at 20 mg/kg were given to seven calves; to five of these calves cefuroxime was also given together with probenecid at 40 mg/kg and at 80 mg/kg. The serum concentration-time data were analyzed using statistical moment theory (SMT). The elimination half-life (t1/2) was 69.2 min (harmonic mean) after i.v. and 64.8 min and 64.9 min following i.m. administration of the lower and higher dose, respectively. Co-administration of probenecid did not affect the t1/2. The mean residence time (MRT) was 80.9 +/- 23.5 min (mean +/- SD) after i.v. and 117.8 +/- 9.3 min and 117.7 +/- 5.4 min after i.m. administration of cefuroxime at 10 and 20 mg/kg, respectively. The MRTi.m. following administration of cefuroxime at 10 mg/kg together with probenecid at 40 mg/kg was 140.0 +/- 8.8 min. The MRTi.m. values were 132.8 +/- 2.3 min and 150.8 +/- 5.1 min after cefuroxime was given at 20 mg/kg together with probenecid at 40 mg/kg or 80 mg/kg, respectively. The total body clearance (ClT) was 3.56 +/- 1.11 ml/min/kg and the volume of distribution at steady state (Vd(ss] 0.270 +/- 0.051 l/kg. The MIC90 values of cefuroxime were 16 micrograms/ml for E. coli and Salmonella isolates, 0.5 microgram/ml for Pasteurella multocida and 2.0 micrograms/ml for P. haemolytica.     

Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle

In the course of vaccine controls, the potency of 25 foot-and-mouth disease (FMD) vaccines was tested quantitatively in parallel in cattle using the intradermal infection and the determination of the SN titres. More than 95% of the vaccinated cattle with SN titres of greater than 1:20 were protected from generalized FMD, regardless of the virus type tested. 61.5% of the vaccinated cattle with SN titres less than or equal to 1:20 were not protected and developed generalized FMD. Comparison of the PD50 values calculated from the results of the intradermal infection and the corresponding SN titres (minimum protection titre greater than 1:20) showed that the results were in complete agreement in 56% of the tested vaccines. In a further 32% of vaccines, the PD50 calculated from the SN titre was slightly below that for the intradermal infection, in the remaining 12% it was somewhat above. The possibility of using the minimum titre determination for testing a vaccine and the significance of this titre as an expression of protection by vaccination are discussed.     

硝酸还原酶与氮素利用的关系及其在作物遗传育种中的应用(综述)

本文综述了硝酸还原酶与氮素利用的关系及其遗传特性和在作物育种中应用的某些最新进展。氮吸收、利用等性状的生理和遗传特性极其复杂,受环境影响很大,对其进行遗传改良需考虑多种指标。对硝酸还原酶活性(NRA)与品质性状和产量的关系的争论很多,有些研究表明 NRA 可作为品质、产量性状的选择指标,有些则相反。逆境条件下 NRA 的变化非常敏感,NRA 可能与抗逆性有关。     

抗绵羊进行性肺炎病毒单克隆抗体杂交瘤细胞株的建立

用提纯的OPPV细胞抗原免疫BALB/c小鼠脾脏与SP2/0小鼠骨髓细胞融合,融合率为70%,以ELISA双抗体夹心法进行检测,阳性率为20%,经过有限稀释法克隆出1A₆、2B₈、1G₃、2G₄4株分泌抗OPPV抗原的单克隆体杂交瘤细胞株.选择抗体分泌滴度高的1A₆细胞进行了较详细的研究,结果表明,其核内染色体数为96～110条,抗体属性为IgG1,轻链为K链,IFA试验表明产生的McAb对OPPV有特异性,细胞传30代并在液氮中保存半年后复苏仍能稳定地分泌抗OPPV McAb,细胞分泌抗体的ELISA滴度腹水为6.4×10⁴,上清为640,McAb经硫基乙醇还原后在SDS-PAG上呈现2条区带,一条为重链部分,MW50000,另一条为轻链部分,MW为25000.     

两端不等弯矩作用下薄壁梁柱的弯扭屈曲

本文采用Ｒａｙｌｅｉｇｈ－Ｒｉｔｚ法求解两端不等弯矩作用下单轴对称开口薄壁截面梁柱弯扭屈曲临界荷载，分析中考虑了三种常见的边界条件以及屈曲前变形的影响，将本文弯扭屈由临界荷载理论值与试验值比较，吻合较好。     

鸡促性腺激素释放激素对卵泡膜分泌雌二醇的影响

本实验选用性成熟的京白种蛋鸡,从同一产蛋顺序中取其发育不同阶段的各级卵泡(F_1～F_4),分离膜层,消化为单个的膜细胞,进行短期细胞培养,着重观察鸡促性腺激素释放激素(GnRH)对培养过程中膜细胞雌二醇分泌的影响.用放射免疫法测定细胞培养液中雌二醇的含量,得到以下结果:①未加外源激素处理的对照组细胞,随着卵泡从小到大的发育成熟过程,膜细胞雌二醇的分泌量逐渐降低;②适当剂量的鸡 GnRH-Ⅱ对各级卵泡膜细胞雌二醇的分泌均有促进作用,其中 F_4,F_3,F_2比 F_1更敏感;③加前体物(孕酮或雄烯二酮)之后,再加鸡 GnRH-Ⅱ比单加前体物或单加鸡 GnRH-Ⅱ,膜细胞雌二醇的分泌量增加更明显.实验结果提示,在体外细胞培养的条件下,GnRH-Ⅱ对膜细胞雌二醇的分泌不仅有促进作用,还可能促进雌二醇的合成。     

Insertion of a transtympanic ventilation tube for the treatment of otitis media with effusion

In this paper, a case of otitis media with effusion (‘glue ear’) is described in a Cavalier King Charles spaniel. Its presentation, diagnosis and surgical management by the insertion of a trans-tympanic ventilation tube (grommet) is discussed.